Donepezil, a well-known cholinesterase inhibitor used in treating Alzheimer’s disease, serves as the positive control, exhibiting nearly complete inhibition of both enzymes (97.59% for AChE and 100% for BChE). Here, BCHE is linked to early-onset autosomal dominant Alzheimer disease.